Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2C | P28335 | 8/20 | 0.56 |
| ▸ | HTR1A | P08908 | 7/20 | 0.55 |
| ▸ | HTR2A | P28223 | 5/20 | 0.55 |
| ▸ | CYP2C9 | P11712 | 4/20 | 0.55 |
| ▸ | HTR2B | P41595 | 4/20 | 0.55 |
| ▸ | CYP2D6 | P10635 | 4/20 | 0.55 |
| ▸ | HTR1D | P28221 | 4/20 | 0.55 |
| ▸ | TSHR | P16473 | 3/20 | 0.55 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.55 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.55 |
| ▸ | HTR1B | P28222 | 2/20 | 0.55 |
| ▸ | HTR7 | P34969 | 2/20 | 0.55 |
| ▸ | HTR3E | A5X5Y0 | 1/20 | 0.55 |
| ▸ | HTR3B | O95264 | 1/20 | 0.55 |
| ▸ | DRD1 | P21728 | 1/20 | 0.55 |
| ▸ | HTR1E | P28566 | 1/20 | 0.55 |
| ▸ | HTR1F | P30939 | 1/20 | 0.55 |
| ▸ | DRD3 | P35462 | 1/20 | 0.55 |
| ▸ | RECQL | P46063 | 1/20 | 0.55 |
| ▸ | HTR3A | P46098 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30686491 | 1.00 | HTR2C (0.56) | HTR2CHTR1AHTR2ACYP2C9HTR2B | |
| Phosphoric Acid SCHEMBL6372496 | 0.90 | NPSR1 (0.50) | HTR2CHTR1AHTR2ACYP2C9HTR2B | |
| SCHEMBL1180662 | 0.84 | NPSR1 (0.51) | HTR2CHTR1AHTR2ACYP2C9HTR2B | |
| SCHEMBL3263472 | 0.82 | HTR2C (0.59) | HTR2CHTR1AHTR2ACYP2C9HTR2B | |
| SCHEMBL5435851 | 0.82 | HTR2C (0.56) | HTR2CHTR1AHTR2ACYP2C9HTR2B | |
| SCHEMBL21291518 | 0.80 | HTR2C (0.55) | HTR2CHTR1AHTR2ACYP2C9HTR2B | |
| SCHEMBL23612158 | 0.78 | HTR2C (0.56) | HTR2CHTR1AHTR2ACYP2C9HTR2B | |
| SCHEMBL17439076 | 0.78 | F7 (0.59) | HTR2ASLC6A4 | |
| SCHEMBL5197534 | 0.78 | HTR2C (0.53) | HTR2CHTR1AHTR2ACYP2C9HTR2B | |
| SCHEMBL21623874 | 0.78 | HPGD (0.50) | HTR2CHTR1AHTR2ACYP2C9HTR2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0271186-B1 | HYDROXYINDOLES AND THEIR USE IN DYEING | REPLIGEN CORPORATION (US) | 1992-12-30 | — | — | EP | claimed |
| US-20240240390-A1 | PROCESS FOR DYEING TEXTILES AND ENZYMES USED THEREIN | SANKO TEKSTIL ISLETMELERI SAN. VE TIC. A.S. (TR) | 2024-07-18 | — | — | US | disclosed |
| CN-114222841-B | Textile dyeing process | 尚科纺织企业工业及贸易公司 | 2024-04-12 | — | — | CN | disclosed |
| US-11920290-B2 | Process for dyeing textiles and enzymes used therein | SANKO TEKSTIL ISLETMELERI SAN. VE TIC A.S. (TR) | 2024-03-05 | — | — | US | disclosed |
| CN-117159588-B | Cell therapy method for treating osteoarthritis by umbilical cord mesenchymal stem cells | 北京国卫生物科技有限公司 | 2024-02-13 | — | — | CN | disclosed |
| CN-117159589-B | Stem cell treatment method for treating systemic lupus erythematosus | 北京国卫生物科技有限公司 | 2024-02-13 | — | — | CN | disclosed |
| CN-117159589-A | Stem cell treatment method for treating systemic lupus erythematosus | 北京国卫生物科技有限公司 | 2023-12-05 | — | — | CN | disclosed |
| CN-117159588-A | Novel cell therapy method for treating osteoarthritis by umbilical cord mesenchymal stem cells | 北京国卫生物科技有限公司 | 2023-12-05 | — | — | CN | disclosed |
| US-20230001024-A1 | CROSS-LINKING COMPOUNDS AND METHODS OF USE THEREOF | NORTH CAROLINA STATE UNIVERSITY | 2023-01-05 | — | — | US | disclosed |
| EP-4003363-A1 | CROSS-LINKING COMPOUNDS AND METHODS OF USE THEREOF | North Carolina State University (US) | 2022-06-01 | — | — | EP | disclosed |
| WO-2021016537-A1 | CROSS-LINKING COMPOUNDS AND METHODS OF USE THEREOF | NORTH CAROLINA STATE UNIVERSITY (US) | 2021-01-28 | — | — | WO | disclosed |
| WO-2021016548-A1 | POLYIODIDE BINDING COMPOUNDS AND METHODS OF USE THEREOF | NORTH CAROLINA STATE UNIVERSITY (US) | 2021-01-28 | — | — | WO | disclosed |
| WO-2021013371-A1 | PROCESS FOR DYEING TEXTILES | SANKO TEKSTIL ISLETMELERI SAN. VE TIC. A.S. (TR) | 2021-01-28 | — | — | WO | disclosed |
| WO-2020015839-A1 | PROCESS AND APPARATUS FOR DYEING TEXTILES | SANKO TEKSTIL ISLETMELERI SAN. VE TIC. A.S. (TR) | 2020-01-23 | — | — | WO | disclosed |
| CN-108129375-A | Compound and preparation method thereof and the application in tumor drug resistance reversal agent is prepared | 中山大学 | 2018-06-08 | — | — | CN | disclosed |
| CN-101563337-A | Indole compounds | MICROBIA INC (US) | 2009-10-21 | — | — | CN | disclosed |
| EP-1765267-A1 | INITIAL PHENYLPROPANEDIOL DYE PRODUCTS | Henkel Kommanditgesellschaft auf Aktien (DE) | 2007-03-28 | — | — | EP | disclosed |
| WO-2006002712-A1 | INITIAL PHENYLPROPANEDIOL DYE PRODUCTS | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2006-01-12 | — | — | WO | disclosed |
| CN-1688549-A | Compound having TGF-beta inhibitory activity and medicinal composition containing the same | KIRIN BREWERY (JP) | 2005-10-26 | — | — | CN | disclosed |
| CN-1141633-A | 4-heterocyclic substituted quinazoline derivatives, process for their preparation and their use as anticancer agents | PFIZER (US) | 1997-01-29 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230001024-A1 | CROSS-LINKING COMPOUNDS AND METHODS OF USE THEREOF | AOX1, MTCL3, COL1A1 | HTR2C 3722/4885HTR1A 4204/4885HTR2A 4136/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.